KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival
Authors:
- Thomas L. EkstromTEThomas L. Ekstrom
- Zhangshuai DaiZDZhangshuai Dai
- Julia ThielJTJulia Thiel
- Akshay KanakanAKAkshay Kanakan
- Bishakha Joyeeta SahaBSBishakha Joyeeta Saha
- Meghana ManjunathMMMeghana Manjunath
- Nadine SchachererNSNadine Schacherer
- Emily L SieglerEmily L Siegler
- Amro M. AbdelrahmanAAAmro M. Abdelrahman
- Frank EssmannFEFrank Essmann
Open Access
- 20 March 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (12) , eaea2106
Abstract
Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal cancer with a 5-year survival rate of 13%. Despite recent molecular stratification of tumors into distinct classical and basal-like cell states, most tumors are heterogeneous and contain both subtypes. Therefore, therapeutic approaches targeting only one subtype are unlikely to be effective as standalone PDAC treatments. Here, we integrated chromatin accessibility [assay for transposase-accessible chromatin with sequencing (ATAC-seq)], genome-wide occupancy [chromatin immunoprecipitation sequencing (ChIP-seq)] for epigenetic status (H3K27ac), and H3K4me3-anchored chromatin topology (HiChIP) to uncover subtype-independent highly interactive enhancers that interact with essential genes in PDAC. Motif analysis revealed that these common enhancers were bound by KLF5 with subsequent depletion leading to decreased cell viability via induction of apoptosis. To elucidate the transcriptional and epigenetic mechanisms by which KLF5 functions in PDAC, we used rapid depletion of KLF5 with dTAG technology and profiled the effects on the open and active chromatin landscape and transcription with nascent RNA and messenger RNA sequencing over time. Enhancer inactivation via KRAB domain Zim3-dCas9 fusion protein confirmed KLF5-bound enhancers regulate target genes, including the anti-apoptotic gene BCL2L1 . Multiplex immunofluorescence confirmed costaining of KLF5 and Bcl-xL in patient samples and overexpression of Bcl-xL rescued the induction of apoptosis after KLF5 depletion. Together, this study provides insights into common mechanisms to target highly heterogeneous PDAC tumors.Keywords
Funding Information
- Robert Bosch Stiftung
- Robert Bosch Stiftung
- Robert Bosch Stiftung
- Robert Bosch Stiftung
This publication has 67 references indexed in Scilit:
- Integrative genomics viewerNature Biotechnology, 2011
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- Krüppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of ApoptosisJournal of Biological Chemistry, 2009
- Krüppel-like factor 5 Is Essential for Blastocyst Development and the Normal Self-Renewal of Mouse ESCsCell Stem Cell, 2008
- Model-based Analysis of ChIP-Seq (MACS)Genome Biology, 2008
- Gene Expression Profile of Metastatic Human Pancreatic Cancer Cells Depends on the Organ MicroenvironmentCancer Research, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- In Vivo Selection and Characterization of Metastatic Variants from Human Pancreatic Adenocarcinoma by Using Orthotopic Implantation in Nude MiceNeoplasia, 1999
- Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.1997